Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-Market
For Immediate Release March 14, 2022 MONTREAL, Canada, March 14, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc.(NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceuticalcompany focused on…